Invesco Biotechnology & Genome ETF PBE | AMEX
|2026-10-15
Company Overview:
10 Year PBE Performance Metrics:
PBE Dividend Payments & Yield
Unlock All Reports & Research Dividend Stocks like a BOSS!
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
PBE Dividends Info:
PBE Dividend History: Dates, Payments & Yield list
Below is a schedule of all PBE dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield
| Ex-Date | Payment Date | Amount | Yield | Forward Yield | Price on Ex-Date |
|---|---|---|---|---|---|
| 09/21/2026 | 09/23/2026 | $0.019 | 0.08% | 0.08% | $96.27 |
| 06/22/2026 | 06/24/2026 | $0.811 | 3.83% | 3.71% | $87.40 |
| 03/23/2026 | 03/25/2026 | $0.082 | 0.43% | 0.42% | $78.07 |
| 12/22/2025 | 12/24/2025 | $0.420 | 2.02% | 2% | $84.16 |
| 09/22/2025 | 09/24/2025 | $0.234 | 1.33% | 1.35% | $69.14 |
| 06/23/2025 | 06/25/2025 | $0.130 | 0.82% | 0.81% | $63.89 |
| 03/24/2025 | 03/26/2025 | $0.034 | 0.2% | 0.21% | $64.89 |
| 06/24/2024 | 06/26/2024 | $0.008 | 0.05% | 0.05% | $65.27 |
| 03/18/2024 | 03/20/2024 | $0.024 | 0.15% | 0.15% | $64.94 |
| 06/20/2023 | 06/22/2023 | $0.014 | 0.09% | 0.09% | $62.41 |
| 03/23/2020 | 03/31/2020 | $0.029 | 0.07% | 0.06% | $46.49 |
| 09/24/2018 | 09/28/2018 | $0.002 | 0% | 0% | $59.45 |
| 06/16/2017 | 06/30/2017 | $0.215 | 0.5% | 0.47% | $45.67 |
| 03/17/2017 | 03/31/2017 | $0.056 | 0.13% | 0.13% | $42.29 |
| 12/16/2016 | 12/30/2016 | $0.121 | 0.29% | 0.31% | $38.81 |
| 09/16/2016 | 09/30/2016 | $0.028 | 0.07% | 0.07% | $41.95 |
| 12/18/2015 | 12/31/2015 | $0.308 | 0.62% | 0.61% | $50.52 |
| 09/18/2015 | 09/30/2015 | $0.137 | 0.25% | 0.3% | $45.72 |
| 06/19/2015 | 06/30/2015 | $0.123 | 0.21% | 0.21% | $58.35 |
| 09/19/2014 | 09/30/2014 | $0.043 | 0.09% | 0.09% | $46.22 |
| 06/20/2014 | 06/30/2014 | $0.234 | 0.53% | 0.54% | $43.71 |
| 12/18/2009 | 11/30/-0001 | $0.076 | 0.47% | 0.47% | $16.16 |
Projected Future Returns & Dividends for PBE
Based on past 10-year performance, here are PBE growth metrics:
Share price CAGR of +9.87%
Dividend CAGR of +10.75%
Using PBE CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| PBE (DRIP) | PBE - No DRIP | |
|---|---|---|
| Current Price | $98.93 | $98.93 |
| Start Shares | 101.08 | 101.08 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 101.89 | 101.08 |
| Dividends Payment | $0.05 | $0.05 |
| Annual Dividends | $22 | $21 |
| Yield on cost | 0.22% | 0.21% |
| Share Price | $253.49 | $253.49 |
| Total Dividends | $128 | $127 |
| Final Value | $25,828 | $25,750 |
NOTE: Above numbers are our estimate based on PBE's Dividend and Price CAGR over past 10 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
Company Info
Invesco Biotechnology & Genome ETF (PBE) had its IPO on 2005-06-23, and is traded on AMEX stock exchange.
The Invesco Biotechnology & Genome ETF (PBE) seeks to replicate the performance of the Dynamic Biotech & Genome Intellidex Index. This fund typically allocates a minimum of 90% of its total assets to the securities comprising the underlying index. The Index is constructed to achieve capital appreciation by thoroughly evaluating companies based on several investment criteria, including their price momentum, earnings growth, overall quality, management decisions, and valuation. It consists of 30 U.S.-based companies within the biotechnology and genome sectors. These companies are primarily involved in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, or they are businesses that stand to gain significantly from scientific and technological breakthroughs in biotechnology and genetic engineering. Both the ETF and its benchmark index undergo quarterly rebalancing and reconstitution in February, May, August, and November.
PBE website: https://www.invesco.com/content/invesco/us/en/financial-products/etfs/invesco-biotechnology-genome-etf.html
Get Full Access to All Reports with DRIPCalc PRO
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
DCF model unavailable for PBE — no fundamentals on file (ETFs and funds are not modelable).
